Results for &quot;&quot;Receptor, Fibroblast Growth Factor, Type 2&quot;&quot;[mesh_terms]

Uralenol, Glycyrol, and Abyssinone II as potent inhibitors of fibroblast growth factor receptor 2 from anti-cancer plants: A deep learning and molecular dynamics approach.

Alomgir Hossain, Md Sanowar Hossan, Md Shahanur Prodhan, Md Nahid Hasan Joy, Muntasir Rahman Siam, Md Ekhtiar Rahman, Mohammad Nurul Matin

PloS one 2026;21(1):e0341498

PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.

Liming Zhao, Jialiang Liu, Kangshuai Li, Chao Zhang, Tianli Chen, Zengli Liu, Yongchang Tang, Xiaoqiang Hu, Anda Shi, Lizhuang Shu, Shaohui Huang, Shuo Lian, Minghui Zhang, Hui Li, Jinpeng Sun, Xiao Yu, Zhongyin Zhang, Zongli Zhang, Yunfei Xu

Hepatology (Baltimore, Md.) 2024;79(4):798-812

Apparently synonymous substitutions in FGFR2 affect splicing and result in mild Crouzon syndrome.

Aimee L Fenwick, Jacqueline A C Goos, Julia Rankin, Helen Lord, Tracy Lester, A Jeannette M Hoogeboom, Ans M W van den Ouweland, Steven A Wall, Irene M J Mathijssen, Andrew O M Wilkie

BMC medical genetics 2014;15():95

A new case of bent bone dysplasia--FGFR2 type and review of the literature.

Morgane Stichelbout, Anne Dieux-Coeslier, Elodie Clouqueur, Corinne Collet, Florence Petit

American journal of medical genetics. Part A 2016;170(3):785-9

Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.

Yann Heuzé, Neus Martínez-Abadías, Jennifer M Stella, Eric Arnaud, Corinne Collet, Gemma García Fructuoso, Mariana Alamar, Lun-Jou Lo, Simeon A Boyadjiev, Federico Di Rocco, Joan T Richtsmeier

Birth defects research. Part A, Clinical and molecular teratology 2014;100(4):250-9

Unclassifiable craniosynostosis phenotypes, FGFR2 Trp290 mutations, acanthosis nigricans, and unpaired cysteine mutations.

M Michael Cohen

American journal of medical genetics 2003;113(1):1-3

Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.

Zev A Wainberg, Peter C Enzinger, Yoon-Koo Kang, Shukui Qin, Kensei Yamaguchi, In-Ho Kim, Anwaar Saeed, Sang Cheul Oh, Jin Li, Haci Mehmet Turk, Alexandra Teixeira, Christophe Borg, Erika Hitre, Adrian A Udrea, Giovanni Gerardo Cardellino, Raquel Guardeño Sanchez, Helen Collins, Siddhartha Mitra, Yingsi Yang, Daniel V T Catenacci, Keun-Wook Lee

The Lancet. Oncology 2022;23(11):1430-1440

Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer.

Ross L Prentice, Ying Huang, David A Hinds, Ulrike Peters, David R Cox, Erica Beilharz, Rowan T Chlebowski, Jacques E Rossouw, Bette Caan, Dennis G Ballinger

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(1):74-9

A case of Beare-Stevenson syndrome with a broad spectrum of features and a review of the FGFR2 Y375C mutation phenotype.

Julie McGaughran, Stephen Sinnott, Rachel Susman, Michael F Buckley, George Elakis, Timothy Cox, Tony Roscioli

Clinical dysmorphology 2009;15(2):89-93

Distinct craniofacial-skeletal-dermatological dysplasia in a patient with W290C mutation in FGFR2.

Vorasuk Shotelersuk, Chupong Ittiwut, Sumarlee Srivuthana, Charan Mahatumarat, Sukalaya Lerdlum, Suthipong Wacharasindhu

American journal of medical genetics 2003;113(1):4-8

Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix.

Francesco Carinci, Furio Pezzetti, Paola Locci, Ennio Becchetti, Friedrick Carls, Anna Avantaggiato, Alessio Becchetti, Paolo Carinci, Tiziano Baroni, Maria Bodo

The Journal of craniofacial surgery 2005;16(3):361-8

Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer.

Kiera Roubal, Zin W Myint, Jill M Kolesar

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2020;77(5):346-351

Tasurgratinib in patients with cholangiocarcinoma or gastric cancer: Expansion part of the first-in-human phase I study.

Maiko Nomoto, Hiroki Ikezawa, Setsuo Funasaka, Atsushi Miyamoto, Masakazu Yashiro, Taisuke Uehara, Tsutomu Takashima, Yoshito Komatsu, Tomohiro Nishina, Masahiro Tajika, Hiroki Hara, Takako Eguchi Nakajima, Makoto Ueno, Chigusa Morizane, Satoru Iwasa, Shuya Takashima, Masayuki Furukawa, Manabu Muto, Toshikazu Moriwaki, Kensei Yamaguchi, Keiko Minashi, Junji Furuse, Masafumi Ikeda, Tatsuya Ioka, Hiroshi Yabusaki, Atsuchi Takeno, Takatoshi Sahara

Cancer science 2025;116(1):192-203

A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2.

Ying Wu, He Gao, Huaixing Li, Yasuharu Tabara, Masahiro Nakatochi, Yen-Feng Chiu, Eun Jung Park, Wanqing Wen, Linda S Adair, Judith B Borja, Qiuyin Cai, Yi-Cheng Chang, Peng Chen, Damien C Croteau-Chonka, Marie P Fogarty, Wei Gan, Chih-Tsueng He, Chao A Hsiung, Chii-Min Hwu, Sahoko Ichihara, Michiya Igase, Jaeseong Jo, Norihiro Kato, Ryuichi Kawamoto, Christophor W Kuzawa, Jeannette J M Lee, Jianjun Liu, Ling Lu, Thomas W McDade, Haruhiko Osawa, Wayne H-H Sheu, Yvonne Teo, Swarooparani Vadlamudi, Rob M Van Dam, Yiqin Wang, Yong-Bing Xiang, Ken Yamamoto, Xingwang Ye, Terri L Young, Wei Zheng, Jingwen Zhu, Xiao-Ou Shu, Chol Shin, Sun Ha Jee, Lee-Ming Chuang, Tetsuro Miki, Mitsuhiro Yokota, Xu Lin, Karen L Mohlke, E Shyong Tai

Human molecular genetics 2014;23(4):1108-19